


BioSyngen
Biotechnology Research • Tampines, East Region, Singapore • 21-50 Employees
Company overview
| Headquarters | 5 Tai Seng Avenue, #08-51, Hougang, North East Community Development Council 536671, SG |
| Phone number | +6569149306 |
| Websites | |
| NAICS | 541714 |
| Keywords | Cell Therapy, Gmp Manufacturing, TIL, Car-T, Solid Tumor, Tcr-T |
| Founded | 2016 |
| Employees | 21-50 |
| Socials |
Key Contact at BioSyngen
Shangyun Sun
Business Development Director
BioSyngen Email Formats
BioSyngen uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@biosyngen.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@biosyngen.com | 100% |
About BioSyngen
Biosyngen is a cell therapy company focusing on unmet needs with technology targeting solid tumors and lymphoproliferative diseases. The company’s first-in-class products have entered into Phase I/II clinical trials for nasopharyngeal cancer (ODD and Fast-Track), lymphoproliferative disease and lung cancer. The company continues to enrich its pipeline with further IND submissions. Biosyngen drives its international strategy from the global headquarter in Singapore, with its clinical center situated in Guangzhou, China. Leverages on the public-private biopharma ecosystem for the better cause. Committed to giving cancer patients a better chance to survive, our pipeline is enriched, covering other major indications which are on track for regulatory registration. Biosyngen seeks breakthrough in collaborations, particularly in translational R&D and clinical development. The company has positioned GMP cell therapy manufacturing facilities in two locations - in Singapore and Guangzhou covering global needs. To quicken drug development from bench-to-bedside, a parallel effort in the form of the Translational Medicine Centre is set up. It is public-private-partnership connecting stakeholders in R&D, Clinical Development, Hospitals, Pharma, Enterprises and Venture Capital. Follow us on LinkedIn. For more information, visit our website at www.biosyngen.com
BioSyngen revenue & valuation
| Annual revenue | $1,796,655 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,800,000 |
| Total funding | $78,200,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
BioSyngen has 9 employees across 5 departments.
Departments
Number of employees
BioSyngen Tech Stack
Discover the technologies and tools that power BioSyngen's digital infrastructure, from frameworks to analytics platforms.
Analytics
JavaScript libraries
JavaScript libraries
Programming languages
Security
Web servers
UI frameworks
Frequently asked questions
4.8
40,000 users



